Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
JCI Insight|June 3, 2020
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapyPei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, et al.
Transplantation and Cellular Therapy|March 23, 2023
Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell TransplantationRichard Newcomb, P Connor Johnson, Katherine Cronin, et al.
Transplantation and Cellular Therapy|November 9, 2025
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy StudiesFrederick L Locke, Sarah Nikiforow, Matthew J Frigault, et al.
Hematological Oncology|June 29, 2023
Cellular therapy in lymphomaAnna Sureda, Pieternella J Lugtenburg, Marie José Kersten, et al.
Transplantation and Cellular Therapy|February 26, 2026
Association between Patient-reported Outcomes Prior to Chimeric Antigen Receptor (CAR) T-cell Therapy and Clinical OutcomesJulia Garcia Mateo, Anna Barata, Tejaswini M Dhawale, et al.
Journal of Pain and Symptom Management|June 23, 2025
Profoundly Depleted: Qualitative Study of Persistent Fatigue Following Hematopoietic Cell TransplantAshley M Nelson, Katherine G Cronin, Ally M Wood, et al.
British Journal of Haematology|January 6, 2016
A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphomaPhilippe Armand, Robert Redd, Jad Bsat, et al.
Pageof 7